Incidence of right-sided colorectal cancer after breast cancer: A population-based study

American Journal of Gastroenterology

Volumn 104, Issue 5, 2009, Pages 1213-1220

  Tang, L Y L ^a   Nugent, Z ^a,b   Demers, A A ^a,b   Singh, Harminder ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b Epidemiology and Cancer Registry   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADULT; AGED; ARTICLE; ASCENDING COLON; BREAST CANCER; CANADA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER REGISTRY; CANCER RISK; CECUM; COLORECTAL CANCER; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; LIVER; MAJOR CLINICAL STUDY; POPULATION; PRIORITY JOURNAL; STANDARDIZED INCIDENCE RATIO; AGE DISTRIBUTION; BREAST TUMOR; CANCER STAGING; COLONOSCOPY; COLORECTAL TUMOR; COMPARATIVE STUDY; CONFIDENCE INTERVAL; INCIDENCE; METASTASIS; METHODOLOGY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PROGNOSIS; REGISTER; RETROSPECTIVE STUDY; RISK ASSESSMENT; SEGMENTAL MASTECTOMY; SURVIVAL RATE;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; COLONOSCOPY; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; CONFIDENCE INTERVALS; FEMALE; HUMANS; INCIDENCE; MANITOBA; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TAMOXIFEN;

EID: 66949141141     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.32     Document Type: Article

References (43)

1. Canadian Cancer Society/National Cancer Institute of Canada. Canadian Cancer Statistics 2008, National Cancer Institute of Canada: Toronto, Canada, 2008.
2. Giordano SH, Hortobagyi GN. Time to remove the subspecialty blinders: breast cancer does not exist in isolation. J Natl Cancer Inst 2008;100: 230-1.
3. Chapman JA, Meng D, Shepherd L et al. Competing causes of death from a randomized trial of extended adjuvant endocrine therapy for breast cancer. J Natl Cancer Inst 2008;100:252-60.
4. Soerjomataram I, Louwman WJ, de VE et al. Primary malignancy after primary female breast cancer in the South of the Netherlands, 1972-2001. Breast Cancer Res Treat 2005;93:91-5.
5. Mellemkjaer L, Friis S, Olsen JH et al. Risk of second cancer among women with breast cancer. Int J Cancer 2006;118:2285-92.
6. Yu GP, Schantz SP, Neugut Al et al. Incidences and trends of second cancers in female breast cancer patients: a fixed inception cohort-based analysis (United States). Cancer Causes Control 2006;17:411-20.
7. Brown LM, Chen BE, Pfeiffer RM et al. Risk of second non-hematological malignancies among 376,825 breast cancer survivors. Breast Cancer Res Treat 2007;106:439-51.
8. Schoen RE, Weissfeld JL, Kuller LH. Are women with breast, endometrial, or ovarian cancer at increased risk for colorectal cancer? Am J Gastroen-terol 1994;89:835-42.
9. Carmichael AR. Obesity as a risk factor for development and poor prognosis of breast cancer. BJOG 2006;113:1160-6.
10. Larsson SC, Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007;86:556-65.
11. Genazzani AR, Gadducci A, Gambacciani M (eds). Hormone replacement therapy and cancer. Gynecol Endocrinol 2001;15:453-65.
12. Schoenfeld P, Cash B, Flood A et al. Colonoscopic screening of average-risk women for colorectal neoplasia. N Engl J Med 2005;352:2061-8.
13. Woods SE, Basho S, Engel A. The Influence of Gender on Colorectal Cancer Stage: The State of Ohio, 1996-2001. J Womens Health 2006;15:877-81.
14. Iacopetta B. Are there two sides to colorectal cancer? Int J Cancer 2002;101:403-8.
15. Nawa T, Kato J, Kawamoto H et al. Differences between right- and left-sided colon cancer in patient characteristics, cancer morphology and histology. J Gastroenterol Hepatol 2008;23:418-23.
16. Gibbons L, Waters C, Mao Y et al. Trends in colorectal cancer incidence and mortality. Health Rep 2001;12:41-55.
17. Travis RC, Key TJ. Oestrogen exposure and breast cancer risk. Breast Cancer Res 2003;5:239-47.
18. Morikawa T, Kato J, Yamaji Y et al. A comparison of the immunochemical fecal occult blood test and total colonoscopy in the asymptomatic population. Gastroenterology 2005;129:422-8.
19. Moss SM, Hardcastle JD, Coleman DA et al. Interval cancers in a randomized controlled trial of screening for colorectal cancer using a faecal occult blood test. Int J Epidemiol 1999;28:386-90.
20. Newcomb PA, Storer BE, Morimoto LM et al. Long-term efficacy of sig-moidoscopy in the reduction of colorectal cancer incidence. J Natl Cancer Inst 2003;95:622-5.
21. Hotes Ellison J, Wu XC, McLaughlin C et al. (eds). Cancer in North America: 1999-2003. Volume one: Incidence. North American Association of Central Cancer Registries Inc.; Sacramento, CA, 2006, p. 11-325.
22. Roos LL, Mustard CA, Nicol JP et al. Registries and administrative data: organization and accuracy. Med Care 1993;31:201-12.
23. Roos Jr LL, Nicol JP, Cageorge SM. Using administrative data for longitudinal research: comparisons with primary data collection. J Chronic Dis 1987;40:41-9.
24. Robinson JR, Young TK, Roos LL et al. Estimating the burden of disease. Comparing administrative data and self-reports. Med Care 1997;35: 932-47.
25. Hennekens CH, Buring JE. Epidemiology in Medicine. Little, Brown and Co.: Boston/Toronto, 1997 p. 82-4.
26. Esteve J, Benhamou E, Raymond L. Statistical methods in cancer research. Descriptive epidemiology. IARC Sci Publ 1994;IV: 1-302.
27. Eisen GM, Sandier RS. Are women with breast cancer more likely to develop colorectal cancer? Critical review and meta-analysis. J Clin Gastroenterol 1994;19:57-63.
28. Srinivasan R, Yang YX, Rubin SC et al. Women with a prior diagnosis of breast cancer are not at an increased risk for subsequent colorectal cancer. Am J Gastroenterol 2005;100:2759-64.
29. Newschaffer CJ, Topham A, Herzberg T et al. Risk of colorectal cancer after breast cancer. Lancet 2001;357:837-40.
30. Ochsenkuhn T, Bayerdorffer E, Meining A et al. Increased prevalence of colorectal adenomas in women with breast cancer. Digestion 2005;72:150-5.
31. Cameron CM, Purdie DM, Kliewer EV et al. Population health and clinical data linkage: the importance of a population registry. Aust N Z J Public Health 2007;31:459-63.
32. Singh H, Demers AA, Xue L et al. Time trends in colon cancer incidence and distribution and lower gastrointestinal endoscopy utilization in Manitoba. Am J Gastroenterol 2008;103:1249-56.
33. Gonzalez EC, Roetzheim RG, Ferrante JM et al. Predictors of proximal vs. distal colorectal cancers. Dis Colon Rectum 2001;44:251-8.
34. Nomoto K, Morotomi M, Miyake M et al. The effects of bile acids on phospholipase C activity in extracts of normal human colon mucosa and primary colon tumors. Mol Carcinog 1994;9:87-94.
35. Distler P, Holt PR. Are right- and left-sided colon neoplasms distinct tumors? Dig Dis 1997;15:302-11.
36. Larsson SC, Rafter J, Holmberg L et al. Red meat consumption and risk of cancers of the proximal colon, distal colon and rectum: the Swedish Mammography Cohort. Int J Cancer 2005;113:829-34.
37. Chao A, Thun MJ, Connell CJ et al. Meat consumption and risk of colorectal cancer. JAMA 2005;293:172-82.
38. Toyomura K, Yamaguchi K, Kawamoto H et al. Relation of cigarette smoking and alcohol use to colorectal adenomas by subsite: the self-defense forces health study. Cancer Sci 2004;95:72-6.
39. Sharpe CR, Siemiatycki J, Rachet B. Effects of alcohol consumption on the risk of colorectal cancer among men by anatomical subsite (Canada). Cancer Causes Control 2002;13:483-91.
40. Newcomb PA, Solomon C, White E. Tamoxifen and risk of large bowel cancer in women with breast cancer. Breast Cancer Res Treat 1999;53: 271-7.
41. Cook LS, Weiss NS, Pharris-Ciurej N et al. Colorectal cancer following tamoxifen therapy for breast cancer (United States). Cancer Causes Control 2001;12:405-10.
42. Matsuyama Y, Tominaga T, Nomura Y et al. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan. Ann Oncol 2000;11:1537-43.
43. Burnand B, Bochud M, Froehlich F et al. 14. Appropriateness of colonosco-py: screening for colorectal cancer in asymptomatic individuals. Endoscopy 1999;31:673-83.